201 related articles for article (PubMed ID: 11921434)
21. Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice.
Gegick CG; Altheimer MD
Endocr Pract; 2001; 7(3):162-9. PubMed ID: 11421562
[TBL] [Abstract][Full Text] [Related]
22. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
23. Thiazolidinediones--the new insulin enhancers.
Jha RJ
Clin Exp Hypertens; 1999; 21(1-2):157-66. PubMed ID: 10052651
[TBL] [Abstract][Full Text] [Related]
24. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
Stafford JM; Elasy T
Vasc Health Risk Manag; 2007; 3(4):503-10. PubMed ID: 17969380
[TBL] [Abstract][Full Text] [Related]
25. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
King AB
Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952
[No Abstract] [Full Text] [Related]
26. [Glitazones. Profile of a new class of substances].
Janka HU
Internist (Berl); 2001 Apr; 42(4):587-96. PubMed ID: 11326741
[No Abstract] [Full Text] [Related]
27. New drugs for diabetes.
Tack CJ; Smits P
Neth J Med; 1999 Nov; 55(5):209-11. PubMed ID: 10593129
[No Abstract] [Full Text] [Related]
28. Troglitazone and related compounds: therapeutic potential beyond diabetes.
Fujiwara T; Horikoshi H
Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone.
Goldstein BJ
Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
[TBL] [Abstract][Full Text] [Related]
30. Thiazolidinediones: a new class of antidiabetic drugs.
Day C
Diabet Med; 1999 Mar; 16(3):179-92. PubMed ID: 10227562
[TBL] [Abstract][Full Text] [Related]
31. Repaglinide in combination therapy.
Moses R
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
[TBL] [Abstract][Full Text] [Related]
32. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
Bloomgarden ZT
Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
[No Abstract] [Full Text] [Related]
33. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.
Malinowski JM; Bolesta S
Clin Ther; 2000 Oct; 22(10):1151-68; discussion 1149-50. PubMed ID: 11110228
[TBL] [Abstract][Full Text] [Related]
34. Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice.
Peters AL
Am J Manag Care; 2001 Apr; 7(3 Suppl):S87-95; quiz S96-7. PubMed ID: 11310177
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone.
Lawrence JM; Reckless JP
Int J Clin Pract; 2000 Nov; 54(9):614-8. PubMed ID: 11220991
[TBL] [Abstract][Full Text] [Related]
36. How should patients taking the discontinued diabetes drug troglitazone be managed?
Reddy SS
Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
[No Abstract] [Full Text] [Related]
37. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
[TBL] [Abstract][Full Text] [Related]
38. [New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000].
Stiefelhagen P
Internist (Berl); 2000 Sep; 41(9):930-2. PubMed ID: 11041699
[No Abstract] [Full Text] [Related]
39. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
40. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
Willi SM; Kennedy A; Brant BP; Wallace P; Rogers NL; Garvey WT
Diabetes Res Clin Pract; 2002 Nov; 58(2):87-96. PubMed ID: 12213349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
